Novel drug holds promise for treating Duchenne muscular dystrophy

A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration.

FDA grants EUA for Novavax’s updated Covid-19 vaccine

Novavax’s updated vaccine is indicated for active vaccination for disease prevention in those aged 12 years and over. Credit: Vladimka production/Shutterstock.com. The US Food and

October 4, 2023

NextGen to Pay $31M Settlement for False Claims Act Allegations

What You Should Know: EHR vendor NextGen Healthcare has agreed to pay $31M to settle allegations that NextGen violated the False Claims Act (FCA) by

July 15, 2023

Breakthrough in pancreatic cancer treatment: Inhibiting specific enzymes slows tumor progression

Study demonstrates that inhibiting stromal class I histone deacetylases (HDACs) can effectively slow down pancreatic cancer progression, shedding light on a new therapeutic approach targeting

December 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.